$ARTH Arch Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Arch Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Arch Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Arch Therapeutics, Inc. for free.

CIK Number: 0001537561
IRS Number: 460524102
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: ARTH
Company Address: 235 WALNUT STREET, SUITE 6 FRAMINGHAM 01702
Phone number: 617-431-2313
Former name: ALMAH,INC, date of change: 2011-12-16

Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.

Market Capitalization: $92.55M
Prev close: $0.68
Average Daily Volume: 328,900
Days Low: $0.67
Year Low: $0.17
Year High: $0.94

Arch Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 23 2020ARTHArch Therapeutics, ...SULAT JAMES RDirectorOption ExerciseP0.25340,91085,228340,910
Jun 23 2020ARTHArch Therapeutics, ...SULAT JAMES RDirectorOption ExerciseO0.18454,54681,8180
Jun 23 2020ARTHArch Therapeutics, ...SULAT JAMES RDirectorBuyO81,818.30454,54637,190,171,9011,376,813922.3 K to 1.4 M (+49.29 %)
Dec 23 2019ARTHArch Therapeutics, ...Norchi Terrence WPresident & CEOOption ExerciseA0.231,000,000229,2001,000,000
Dec 23 2019ARTHArch Therapeutics, ...DAVIS RICHARD ECFO & TreasurerOption ExerciseA0.23700,000160,440700,000
Dec 23 2019ARTHArch Therapeutics, ...SULAT JAMES RDirectorOption ExerciseA0.23300,00068,760300,000
Dec 23 2019ARTHArch Therapeutics, ...DHILLON PUNITDirectorOption ExerciseA0.23300,00068,760300,000
Jul 20 2018ARTHArch Therapeutics, ...SULAT JAMES RDirectorOption ExerciseA0.43110,00046,750110,000
Jul 20 2018ARTHArch Therapeutics, ...SULAT JAMES RDirectorGrantA0.00110,0000370,000260 K to 370 K (+42.31 %)
Jul 20 2018ARTHArch Therapeutics, ...Norchi Terrence WPresident & CEOOption ExerciseA0.43360,000153,000360,000
Jul 20 2018ARTHArch Therapeutics, ...Norchi Terrence WPresident & CEOGrantA0.00360,00003,559,0763.2 M to 3.6 M (+11.25 %)
Jul 20 2018ARTHArch Therapeutics, ...DAVIS RICHARD ECFO & TreasurerOption ExerciseA0.43275,000116,875275,000
Jul 20 2018ARTHArch Therapeutics, ...DAVIS RICHARD ECFO & TreasurerGrantA0.00275,0000878,000603 K to 878 K (+45.61 %)
Jul 20 2018ARTHArch Therapeutics, ...DHILLON PUNITDirectorOption ExerciseA0.43200,00085,000200,000
Jul 20 2018ARTHArch Therapeutics, ...DHILLON AVTAR SDirectorOption ExerciseA0.43220,00093,500220,000

View all Arch Therapeutics, Inc. insider transactions.